 |
International Breast Cancer research updates
-
New generation cancer drug specifically targets hereditary cancer [June 2009]
A UK clinical trial shows very promising results for a new kind of cancer drug which specifically targets hereditary cancer caused by faulty BRCA1 and BRCA2 genes. The small scale patient trial has shown remarkable benefit for patients with breast, ovarian and prostate cancer. Read more -
Partial Irradiation is Cost Effective in Breast Cancer [June 2009]
Accelerated partial-breast irradiation (PBI) appears to be a particularly cost-effective treatment for certain patients with early-stage breast cancer. Read More -
Bisphosphonates may prolong survival in metastatic breast cancer patients [June 2009]
IV bisphosphonate in addition to chemotherapy or hormonal therapy has an anti-tumor effect on hormone receptor (HR)-negative breast cancer patients with bone metastases, who may gain a survival advantage, according to Korean researchers. Read more - Gene explains breast cancer chemotherapy outcomes [June 2009]
Genetic mutations can show which breast cancer patients will be helped by a certain type of chemotherapy, U.S. researchers have reported. Read more
